nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—SLC22A5—Crohn's disease	0.504	0.783	CbGaD
Furosemide—ALB—Crohn's disease	0.14	0.217	CbGaD
Furosemide—SLC22A8—Mercaptopurine—Crohn's disease	0.0838	0.462	CbGbCtD
Furosemide—ABCC2—Sulfasalazine—Crohn's disease	0.065	0.359	CbGbCtD
Furosemide—ALB—Prednisone—Crohn's disease	0.0324	0.179	CbGbCtD
Furosemide—ABCC2—bile—Crohn's disease	0.00587	0.132	CbGeAlD
Furosemide—CA9—gall bladder—Crohn's disease	0.00338	0.0758	CbGeAlD
Furosemide—CA6—mouth—Crohn's disease	0.00331	0.0743	CbGeAlD
Furosemide—SLC22A5—Organic cation transport—SLC22A4—Crohn's disease	0.00322	0.0725	CbGpPWpGaD
Furosemide—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00259	0.0583	CbGpPWpGaD
Furosemide—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00259	0.0583	CbGpPWpGaD
Furosemide—Angiitis necrotising—Prednisone—Crohn's disease	0.00229	0.0267	CcSEcCtD
Furosemide—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00218	0.0492	CbGpPWpGaD
Furosemide—Glucose tolerance decreased—Prednisone—Crohn's disease	0.00208	0.0243	CcSEcCtD
Furosemide—Vasculitis necrotising—Prednisone—Crohn's disease	0.00199	0.0233	CcSEcCtD
Furosemide—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00197	0.0445	CbGpPWpGaD
Furosemide—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00197	0.0445	CbGpPWpGaD
Furosemide—Cholestasis—Mercaptopurine—Crohn's disease	0.00192	0.0224	CcSEcCtD
Furosemide—ALB—gall bladder—Crohn's disease	0.00174	0.039	CbGeAlD
Furosemide—Pancreatitis acute—Mesalazine—Crohn's disease	0.00171	0.02	CcSEcCtD
Furosemide—Abdominal bloating—Mesalazine—Crohn's disease	0.00166	0.0194	CcSEcCtD
Furosemide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00165	0.0371	CbGpPWpGaD
Furosemide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00165	0.0371	CbGpPWpGaD
Furosemide—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.00157	0.0183	CcSEcCtD
Furosemide—Glucose tolerance impaired—Prednisone—Crohn's disease	0.00155	0.0181	CcSEcCtD
Furosemide—CA7—digestive system—Crohn's disease	0.00151	0.034	CbGeAlD
Furosemide—SLC12A1—epithelium—Crohn's disease	0.00149	0.0334	CbGeAlD
Furosemide—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.00148	0.0173	CcSEcCtD
Furosemide—Local reaction—Mesalazine—Crohn's disease	0.00143	0.0166	CcSEcCtD
Furosemide—SLCO2A1—epithelium—Crohn's disease	0.00137	0.0308	CbGeAlD
Furosemide—SLCO2A1—Transport of organic anions—ALB—Crohn's disease	0.00133	0.03	CbGpPWpGaD
Furosemide—CA9—digestive system—Crohn's disease	0.00133	0.0298	CbGeAlD
Furosemide—SLCO2A1—skin of body—Crohn's disease	0.00131	0.0293	CbGeAlD
Furosemide—CA2—gall bladder—Crohn's disease	0.00128	0.0288	CbGeAlD
Furosemide—Hypomagnesaemia—Mesalazine—Crohn's disease	0.00124	0.0145	CcSEcCtD
Furosemide—SLCO2A1—mammalian vulva—Crohn's disease	0.00119	0.0267	CbGeAlD
Furosemide—PGD—smooth muscle tissue—Crohn's disease	0.00118	0.0265	CbGeAlD
Furosemide—Nephritis interstitial—Mesalazine—Crohn's disease	0.00117	0.0137	CcSEcCtD
Furosemide—SLC22A11—digestive system—Crohn's disease	0.00117	0.0261	CbGeAlD
Furosemide—PGD—skin of body—Crohn's disease	0.00116	0.0261	CbGeAlD
Furosemide—Cholestasis—Azathioprine—Crohn's disease	0.00114	0.0133	CcSEcCtD
Furosemide—CA2—mouth—Crohn's disease	0.00114	0.0256	CbGeAlD
Furosemide—Thrombosis—Mesalazine—Crohn's disease	0.00112	0.013	CcSEcCtD
Furosemide—Blister—Mesalazine—Crohn's disease	0.0011	0.0128	CcSEcCtD
Furosemide—Gastric irritation—Prednisone—Crohn's disease	0.00108	0.0126	CcSEcCtD
Furosemide—PGD—mammalian vulva—Crohn's disease	0.00106	0.0238	CbGeAlD
Furosemide—Cholestasis—Mesalazine—Crohn's disease	0.00104	0.0121	CcSEcCtD
Furosemide—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.00103	0.012	CcSEcCtD
Furosemide—CA5B—mammalian vulva—Crohn's disease	0.00101	0.0226	CbGeAlD
Furosemide—Jaundice cholestatic—Azathioprine—Crohn's disease	0.000987	0.0115	CcSEcCtD
Furosemide—CA12—digestive system—Crohn's disease	0.000984	0.0221	CbGeAlD
Furosemide—PGD—lymphoid tissue—Crohn's disease	0.000943	0.0212	CbGeAlD
Furosemide—PGD—digestive system—Crohn's disease	0.000932	0.0209	CbGeAlD
Furosemide—Pancreatitis acute—Prednisone—Crohn's disease	0.000905	0.0106	CcSEcCtD
Furosemide—Jaundice cholestatic—Mesalazine—Crohn's disease	0.000899	0.0105	CcSEcCtD
Furosemide—Pancreatitis—Mercaptopurine—Crohn's disease	0.000895	0.0104	CcSEcCtD
Furosemide—Vasculitis—Azathioprine—Crohn's disease	0.000888	0.0104	CcSEcCtD
Furosemide—CA9—Cellular response to hypoxia—RBX1—Crohn's disease	0.000869	0.0196	CbGpPWpGaD
Furosemide—Hypocalcaemia—Mesalazine—Crohn's disease	0.000862	0.0101	CcSEcCtD
Furosemide—Gout—Mesalazine—Crohn's disease	0.000846	0.00987	CcSEcCtD
Furosemide—Aplastic anaemia—Azathioprine—Crohn's disease	0.000814	0.0095	CcSEcCtD
Furosemide—Epigastric discomfort—Prednisone—Crohn's disease	0.000795	0.00928	CcSEcCtD
Furosemide—CA1—lymphoid tissue—Crohn's disease	0.000789	0.0177	CbGeAlD
Furosemide—CA1—digestive system—Crohn's disease	0.000779	0.0175	CbGeAlD
Furosemide—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00077	0.00899	CcSEcCtD
Furosemide—CA9—Cellular response to hypoxia—UBE2D1—Crohn's disease	0.000762	0.0172	CbGpPWpGaD
Furosemide—Aplastic anaemia—Mesalazine—Crohn's disease	0.000741	0.00865	CcSEcCtD
Furosemide—Cramps of lower extremities—Mesalazine—Crohn's disease	0.000725	0.00847	CcSEcCtD
Furosemide—Bladder pain—Mesalazine—Crohn's disease	0.000714	0.00833	CcSEcCtD
Furosemide—CA2—epithelium—Crohn's disease	0.000664	0.0149	CbGeAlD
Furosemide—Immune system disorder—Mercaptopurine—Crohn's disease	0.00066	0.0077	CcSEcCtD
Furosemide—Photosensitivity—Mesalazine—Crohn's disease	0.000653	0.00762	CcSEcCtD
Furosemide—ABCC2—digestive system—Crohn's disease	0.000641	0.0144	CbGeAlD
Furosemide—Deafness—Mesalazine—Crohn's disease	0.000641	0.00748	CcSEcCtD
Furosemide—CA2—smooth muscle tissue—Crohn's disease	0.00064	0.0143	CbGeAlD
Furosemide—Blood triglycerides increased—Prednisone—Crohn's disease	0.000638	0.00744	CcSEcCtD
Furosemide—Malnutrition—Mercaptopurine—Crohn's disease	0.000636	0.00742	CcSEcCtD
Furosemide—CA2—skin of body—Crohn's disease	0.000631	0.0142	CbGeAlD
Furosemide—SLC22A5—skin of body—Crohn's disease	0.000621	0.0139	CbGeAlD
Furosemide—CA4—digestive system—Crohn's disease	0.000609	0.0137	CbGeAlD
Furosemide—Thirst—Mesalazine—Crohn's disease	0.000602	0.00703	CcSEcCtD
Furosemide—Dermatitis bullous—Mesalazine—Crohn's disease	0.0006	0.007	CcSEcCtD
Furosemide—SLCO2A1—lymph node—Crohn's disease	0.000597	0.0134	CbGeAlD
Furosemide—Anaemia—Mercaptopurine—Crohn's disease	0.000588	0.00686	CcSEcCtD
Furosemide—Lethargy—Mesalazine—Crohn's disease	0.000585	0.00683	CcSEcCtD
Furosemide—CA2—mammalian vulva—Crohn's disease	0.000576	0.0129	CbGeAlD
Furosemide—Leukopenia—Mercaptopurine—Crohn's disease	0.000569	0.00665	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000567	0.00662	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000538	0.00628	CcSEcCtD
Furosemide—Blood creatinine increased—Mesalazine—Crohn's disease	0.000537	0.00627	CcSEcCtD
Furosemide—Pancreatitis—Azathioprine—Crohn's disease	0.000533	0.00623	CcSEcCtD
Furosemide—PGD—lymph node—Crohn's disease	0.000532	0.0119	CbGeAlD
Furosemide—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000523	0.00611	CcSEcCtD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000519	0.0117	CbGpPWpGaD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000519	0.0117	CbGpPWpGaD
Furosemide—Cramp muscle—Mesalazine—Crohn's disease	0.000516	0.00603	CcSEcCtD
Furosemide—Glycosuria—Prednisone—Crohn's disease	0.000516	0.00602	CcSEcCtD
Furosemide—CA2—lymphoid tissue—Crohn's disease	0.000511	0.0115	CbGeAlD
Furosemide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000508	0.00593	CcSEcCtD
Furosemide—CA2—digestive system—Crohn's disease	0.000505	0.0113	CbGeAlD
Furosemide—Skin disorder—Mercaptopurine—Crohn's disease	0.000504	0.00589	CcSEcCtD
Furosemide—CA5B—lymph node—Crohn's disease	0.000504	0.0113	CbGeAlD
Furosemide—Abdominal distension—Mesalazine—Crohn's disease	0.000499	0.00582	CcSEcCtD
Furosemide—SLC22A5—digestive system—Crohn's disease	0.000497	0.0111	CbGeAlD
Furosemide—Anorexia—Mercaptopurine—Crohn's disease	0.000495	0.00578	CcSEcCtD
Furosemide—SLCO2A1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000494	0.0111	CbGpPWpGaD
Furosemide—Eosinophilia—Mesalazine—Crohn's disease	0.00049	0.00573	CcSEcCtD
Furosemide—Pancreatitis—Mesalazine—Crohn's disease	0.000486	0.00567	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000481	0.00561	CcSEcCtD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000473	0.0107	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000473	0.0107	CbGpPWpGaD
Furosemide—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000459	0.00535	CcSEcCtD
Furosemide—Pollakiuria—Mesalazine—Crohn's disease	0.000458	0.00534	CcSEcCtD
Furosemide—Agranulocytosis—Azathioprine—Crohn's disease	0.000453	0.00528	CcSEcCtD
Furosemide—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000452	0.00528	CcSEcCtD
Furosemide—Decreased appetite—Mercaptopurine—Crohn's disease	0.000451	0.00527	CcSEcCtD
Furosemide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000448	0.00523	CcSEcCtD
Furosemide—CA1—lymph node—Crohn's disease	0.000445	0.00998	CbGeAlD
Furosemide—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000438	0.00511	CcSEcCtD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000437	0.00985	CbGpPWpGaD
Furosemide—Renal failure—Mesalazine—Crohn's disease	0.000434	0.00507	CcSEcCtD
Furosemide—Vasculitis—Prednisone—Crohn's disease	0.000428	0.005	CcSEcCtD
Furosemide—Sweating—Mesalazine—Crohn's disease	0.000423	0.00494	CcSEcCtD
Furosemide—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000418	0.00488	CcSEcCtD
Furosemide—Agranulocytosis—Mesalazine—Crohn's disease	0.000412	0.00481	CcSEcCtD
Furosemide—Erythema multiforme—Azathioprine—Crohn's disease	0.000412	0.00481	CcSEcCtD
Furosemide—Body temperature increased—Mercaptopurine—Crohn's disease	0.00041	0.00479	CcSEcCtD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000396	0.00891	CbGpPWpGaD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000396	0.00891	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000395	0.00889	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000395	0.00889	CbGpPWpGaD
Furosemide—Immune system disorder—Azathioprine—Crohn's disease	0.000393	0.00459	CcSEcCtD
Furosemide—Urinary tract disorder—Mesalazine—Crohn's disease	0.000392	0.00457	CcSEcCtD
Furosemide—ALB—lymph node—Crohn's disease	0.000391	0.00877	CbGeAlD
Furosemide—CA1—C-MYB transcription factor network—MPO—Crohn's disease	0.000391	0.0088	CbGpPWpGaD
Furosemide—Arrhythmia—Azathioprine—Crohn's disease	0.000389	0.00454	CcSEcCtD
Furosemide—Urethral disorder—Mesalazine—Crohn's disease	0.000389	0.00454	CcSEcCtD
Furosemide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000382	0.00446	CcSEcCtD
Furosemide—Erythema multiforme—Mesalazine—Crohn's disease	0.000375	0.00438	CcSEcCtD
Furosemide—Eye disorder—Mesalazine—Crohn's disease	0.000371	0.00433	CcSEcCtD
Furosemide—Tinnitus—Mesalazine—Crohn's disease	0.00037	0.00432	CcSEcCtD
Furosemide—ABCC2—lymph node—Crohn's disease	0.000366	0.00822	CbGeAlD
Furosemide—Angiopathy—Mesalazine—Crohn's disease	0.00036	0.0042	CcSEcCtD
Furosemide—Immune system disorder—Mesalazine—Crohn's disease	0.000358	0.00418	CcSEcCtD
Furosemide—Diarrhoea—Mercaptopurine—Crohn's disease	0.000355	0.00415	CcSEcCtD
Furosemide—Thrombophlebitis—Prednisone—Crohn's disease	0.00035	0.00409	CcSEcCtD
Furosemide—Anaemia—Azathioprine—Crohn's disease	0.00035	0.00409	CcSEcCtD
Furosemide—Diabetes mellitus—Prednisone—Crohn's disease	0.000349	0.00407	CcSEcCtD
Furosemide—CA4—lymph node—Crohn's disease	0.000348	0.0078	CbGeAlD
Furosemide—Erythema—Mesalazine—Crohn's disease	0.000345	0.00403	CcSEcCtD
Furosemide—Flatulence—Mesalazine—Crohn's disease	0.00034	0.00397	CcSEcCtD
Furosemide—Leukopenia—Azathioprine—Crohn's disease	0.000339	0.00396	CcSEcCtD
Furosemide—Vascular purpura—Prednisone—Crohn's disease	0.000339	0.00396	CcSEcCtD
Furosemide—Dysgeusia—Mesalazine—Crohn's disease	0.000338	0.00395	CcSEcCtD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000333	0.00751	CbGpPWpGaD
Furosemide—Muscle spasms—Mesalazine—Crohn's disease	0.000332	0.00387	CcSEcCtD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00033	0.00743	CbGpPWpGaD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00033	0.00743	CbGpPWpGaD
Furosemide—Vomiting—Mercaptopurine—Crohn's disease	0.00033	0.00385	CcSEcCtD
Furosemide—Rash—Mercaptopurine—Crohn's disease	0.000327	0.00382	CcSEcCtD
Furosemide—Dermatitis—Mercaptopurine—Crohn's disease	0.000327	0.00382	CcSEcCtD
Furosemide—Vision blurred—Mesalazine—Crohn's disease	0.000325	0.0038	CcSEcCtD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000323	0.00727	CbGpPWpGaD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00032	0.00374	CcSEcCtD
Furosemide—Anaemia—Mesalazine—Crohn's disease	0.000319	0.00372	CcSEcCtD
Furosemide—Purpura—Prednisone—Crohn's disease	0.000315	0.00367	CcSEcCtD
Furosemide—Vertigo—Mesalazine—Crohn's disease	0.00031	0.00362	CcSEcCtD
Furosemide—Lethargy—Prednisone—Crohn's disease	0.000309	0.00361	CcSEcCtD
Furosemide—Leukopenia—Mesalazine—Crohn's disease	0.000309	0.00361	CcSEcCtD
Furosemide—Nausea—Mercaptopurine—Crohn's disease	0.000308	0.0036	CcSEcCtD
Furosemide—PGD—Carbohydrate metabolism—GCKR—Crohn's disease	0.000306	0.00689	CbGpPWpGaD
Furosemide—Thrombocytopenia—Azathioprine—Crohn's disease	0.000303	0.00354	CcSEcCtD
Furosemide—Skin disorder—Azathioprine—Crohn's disease	0.0003	0.00351	CcSEcCtD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000295	0.00664	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—TAB1—Crohn's disease	0.000294	0.00663	CbGpPWpGaD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000292	0.00341	CcSEcCtD
Furosemide—Irritability—Prednisone—Crohn's disease	0.000289	0.00338	CcSEcCtD
Furosemide—Hypotension—Azathioprine—Crohn's disease	0.000289	0.00337	CcSEcCtD
Furosemide—CA2—lymph node—Crohn's disease	0.000288	0.00647	CbGeAlD
Furosemide—Dry mouth—Mesalazine—Crohn's disease	0.000287	0.00336	CcSEcCtD
Furosemide—Confusional state—Mesalazine—Crohn's disease	0.000284	0.00332	CcSEcCtD
Furosemide—SLC22A5—lymph node—Crohn's disease	0.000284	0.00637	CbGeAlD
Furosemide—Anaphylactic shock—Mesalazine—Crohn's disease	0.000282	0.00329	CcSEcCtD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000278	0.00627	CbGpPWpGaD
Furosemide—Shock—Mesalazine—Crohn's disease	0.000277	0.00324	CcSEcCtD
Furosemide—Nervous system disorder—Mesalazine—Crohn's disease	0.000276	0.00323	CcSEcCtD
Furosemide—Hypokalaemia—Prednisone—Crohn's disease	0.000276	0.00322	CcSEcCtD
Furosemide—Thrombocytopenia—Mesalazine—Crohn's disease	0.000276	0.00322	CcSEcCtD
Furosemide—Skin disorder—Mesalazine—Crohn's disease	0.000274	0.00319	CcSEcCtD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000272	0.00613	CbGpPWpGaD
Furosemide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000272	0.00318	CcSEcCtD
Furosemide—Anorexia—Mesalazine—Crohn's disease	0.000269	0.00313	CcSEcCtD
Furosemide—Muscular weakness—Prednisone—Crohn's disease	0.000267	0.00312	CcSEcCtD
Furosemide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000267	0.00312	CcSEcCtD
Furosemide—Abdominal distension—Prednisone—Crohn's disease	0.000264	0.00308	CcSEcCtD
Furosemide—Hypotension—Mesalazine—Crohn's disease	0.000263	0.00307	CcSEcCtD
Furosemide—Pancreatitis—Prednisone—Crohn's disease	0.000257	0.003	CcSEcCtD
Furosemide—Feeling abnormal—Azathioprine—Crohn's disease	0.000255	0.00298	CcSEcCtD
Furosemide—Paraesthesia—Mesalazine—Crohn's disease	0.000253	0.00295	CcSEcCtD
Furosemide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000253	0.00295	CcSEcCtD
Furosemide—CA9—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000251	0.00565	CbGpPWpGaD
Furosemide—Somnolence—Mesalazine—Crohn's disease	0.00025	0.00292	CcSEcCtD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000246	0.00555	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000246	0.00554	CbGpPWpGaD
Furosemide—Decreased appetite—Mesalazine—Crohn's disease	0.000245	0.00286	CcSEcCtD
Furosemide—Body temperature increased—Azathioprine—Crohn's disease	0.000244	0.00285	CcSEcCtD
Furosemide—Abdominal pain—Azathioprine—Crohn's disease	0.000244	0.00285	CcSEcCtD
Furosemide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000243	0.00284	CcSEcCtD
Furosemide—Fatigue—Mesalazine—Crohn's disease	0.000243	0.00284	CcSEcCtD
Furosemide—Constipation—Mesalazine—Crohn's disease	0.000241	0.00281	CcSEcCtD
Furosemide—Pain—Mesalazine—Crohn's disease	0.000241	0.00281	CcSEcCtD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000241	0.00541	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000241	0.00541	CbGpPWpGaD
Furosemide—Hyperglycaemia—Prednisone—Crohn's disease	0.000236	0.00276	CcSEcCtD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000236	0.00531	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000236	0.00531	CbGpPWpGaD
Furosemide—Feeling abnormal—Mesalazine—Crohn's disease	0.000232	0.00271	CcSEcCtD
Furosemide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00023	0.00269	CcSEcCtD
Furosemide—Hypersensitivity—Azathioprine—Crohn's disease	0.000228	0.00266	CcSEcCtD
Furosemide—Urticaria—Mesalazine—Crohn's disease	0.000224	0.00261	CcSEcCtD
Furosemide—Abdominal pain—Mesalazine—Crohn's disease	0.000223	0.0026	CcSEcCtD
Furosemide—Body temperature increased—Mesalazine—Crohn's disease	0.000223	0.0026	CcSEcCtD
Furosemide—Diarrhoea—Azathioprine—Crohn's disease	0.000212	0.00247	CcSEcCtD
Furosemide—Hypersensitivity—Mesalazine—Crohn's disease	0.000208	0.00242	CcSEcCtD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000206	0.00463	CbGpPWpGaD
Furosemide—Dizziness—Azathioprine—Crohn's disease	0.000205	0.00239	CcSEcCtD
Furosemide—Asthenia—Mesalazine—Crohn's disease	0.000202	0.00236	CcSEcCtD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000201	0.00452	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000201	0.00452	CbGpPWpGaD
Furosemide—Pruritus—Mesalazine—Crohn's disease	0.000199	0.00233	CcSEcCtD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000199	0.00447	CbGpPWpGaD
Furosemide—Vomiting—Azathioprine—Crohn's disease	0.000197	0.0023	CcSEcCtD
Furosemide—Eye disorder—Prednisone—Crohn's disease	0.000196	0.00229	CcSEcCtD
Furosemide—Rash—Azathioprine—Crohn's disease	0.000195	0.00228	CcSEcCtD
Furosemide—Dermatitis—Azathioprine—Crohn's disease	0.000195	0.00227	CcSEcCtD
Furosemide—Headache—Azathioprine—Crohn's disease	0.000194	0.00226	CcSEcCtD
Furosemide—Diarrhoea—Mesalazine—Crohn's disease	0.000193	0.00225	CcSEcCtD
Furosemide—Angiopathy—Prednisone—Crohn's disease	0.00019	0.00222	CcSEcCtD
Furosemide—Immune system disorder—Prednisone—Crohn's disease	0.000189	0.00221	CcSEcCtD
Furosemide—Arrhythmia—Prednisone—Crohn's disease	0.000187	0.00219	CcSEcCtD
Furosemide—Dizziness—Mesalazine—Crohn's disease	0.000186	0.00217	CcSEcCtD
Furosemide—Nausea—Azathioprine—Crohn's disease	0.000184	0.00214	CcSEcCtD
Furosemide—Erythema—Prednisone—Crohn's disease	0.000183	0.00213	CcSEcCtD
Furosemide—Malnutrition—Prednisone—Crohn's disease	0.000183	0.00213	CcSEcCtD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00018	0.00405	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00018	0.00405	CbGpPWpGaD
Furosemide—Vomiting—Mesalazine—Crohn's disease	0.000179	0.00209	CcSEcCtD
Furosemide—Rash—Mesalazine—Crohn's disease	0.000178	0.00207	CcSEcCtD
Furosemide—Dermatitis—Mesalazine—Crohn's disease	0.000177	0.00207	CcSEcCtD
Furosemide—Headache—Mesalazine—Crohn's disease	0.000176	0.00206	CcSEcCtD
Furosemide—Vision blurred—Prednisone—Crohn's disease	0.000172	0.00201	CcSEcCtD
Furosemide—ALB—Folate Metabolism—GPX4—Crohn's disease	0.00017	0.00384	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000169	0.00381	CbGpPWpGaD
Furosemide—Anaemia—Prednisone—Crohn's disease	0.000169	0.00197	CcSEcCtD
Furosemide—Agitation—Prednisone—Crohn's disease	0.000168	0.00196	CcSEcCtD
Furosemide—Nausea—Mesalazine—Crohn's disease	0.000167	0.00195	CcSEcCtD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000166	0.00374	CbGpPWpGaD
Furosemide—Vertigo—Prednisone—Crohn's disease	0.000164	0.00192	CcSEcCtD
Furosemide—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	0.00016	0.00359	CbGpPWpGaD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000154	0.0018	CcSEcCtD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00015	0.00338	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00015	0.00338	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00015	0.00337	CbGpPWpGaD
Furosemide—Anaphylactic shock—Prednisone—Crohn's disease	0.000149	0.00174	CcSEcCtD
Furosemide—ALB—Platelet degranulation—F5—Crohn's disease	0.000148	0.00333	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000147	0.0033	CbGpPWpGaD
Furosemide—Shock—Prednisone—Crohn's disease	0.000147	0.00171	CcSEcCtD
Furosemide—Nervous system disorder—Prednisone—Crohn's disease	0.000146	0.00171	CcSEcCtD
Furosemide—Skin disorder—Prednisone—Crohn's disease	0.000145	0.00169	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisone—Crohn's disease	0.000144	0.00168	CcSEcCtD
Furosemide—Anorexia—Prednisone—Crohn's disease	0.000142	0.00166	CcSEcCtD
Furosemide—SLC12A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000141	0.00318	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	0.000141	0.00317	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00014	0.00315	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—CD4—Crohn's disease	0.000139	0.00312	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—PTGS2—Crohn's disease	0.000138	0.0031	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000135	0.00305	CbGpPWpGaD
Furosemide—Paraesthesia—Prednisone—Crohn's disease	0.000134	0.00156	CcSEcCtD
Furosemide—CA9—Cellular responses to stress—RBX1—Crohn's disease	0.000132	0.00297	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—HSPA1B—Crohn's disease	0.000132	0.00297	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—MPO—Crohn's disease	0.00013	0.00292	CbGpPWpGaD
Furosemide—Decreased appetite—Prednisone—Crohn's disease	0.00013	0.00151	CcSEcCtD
Furosemide—CA14—Metabolism—PLA2G4F—Crohn's disease	0.000129	0.0029	CbGpPWpGaD
Furosemide—Fatigue—Prednisone—Crohn's disease	0.000128	0.0015	CcSEcCtD
Furosemide—Constipation—Prednisone—Crohn's disease	0.000127	0.00149	CcSEcCtD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000127	0.00285	CbGpPWpGaD
Furosemide—PGD—Disease—RSPO3—Crohn's disease	0.000126	0.00285	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PLA2G4F—Crohn's disease	0.000126	0.00283	CbGpPWpGaD
Furosemide—CA6—Metabolism—PLA2G4F—Crohn's disease	0.000126	0.00283	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000125	0.00281	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000124	0.00279	CbGpPWpGaD
Furosemide—Feeling abnormal—Prednisone—Crohn's disease	0.000123	0.00143	CcSEcCtD
Furosemide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000122	0.00142	CcSEcCtD
Furosemide—PGD—Metabolism—PLA2G4F—Crohn's disease	0.000121	0.00273	CbGpPWpGaD
Furosemide—PGD—Disease—SEL1L—Crohn's disease	0.00012	0.0027	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00012	0.0027	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00012	0.0027	CbGpPWpGaD
Furosemide—Urticaria—Prednisone—Crohn's disease	0.000118	0.00138	CcSEcCtD
Furosemide—Body temperature increased—Prednisone—Crohn's disease	0.000118	0.00138	CcSEcCtD
Furosemide—Abdominal pain—Prednisone—Crohn's disease	0.000118	0.00138	CcSEcCtD
Furosemide—CA7—Metabolism—PLA2G4F—Crohn's disease	0.000117	0.00264	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PLA2G4F—Crohn's disease	0.000117	0.00264	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—UBE2D1—Crohn's disease	0.000116	0.0026	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000112	0.00252	CbGpPWpGaD
Furosemide—Hypersensitivity—Prednisone—Crohn's disease	0.00011	0.00128	CcSEcCtD
Furosemide—CA14—Metabolism—MTMR3—Crohn's disease	0.00011	0.00247	CbGpPWpGaD
Furosemide—CA12—Metabolism—PLA2G4F—Crohn's disease	0.000109	0.00245	CbGpPWpGaD
Furosemide—PGD—Disease—LTF—Crohn's disease	0.000108	0.00242	CbGpPWpGaD
Furosemide—Asthenia—Prednisone—Crohn's disease	0.000107	0.00125	CcSEcCtD
Furosemide—CA6—Metabolism—MTMR3—Crohn's disease	0.000107	0.0024	CbGpPWpGaD
Furosemide—CA5A—Metabolism—MTMR3—Crohn's disease	0.000107	0.0024	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000106	0.00239	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000106	0.00238	CbGpPWpGaD
Furosemide—Pruritus—Prednisone—Crohn's disease	0.000105	0.00123	CcSEcCtD
Furosemide—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	0.000103	0.00232	CbGpPWpGaD
Furosemide—PGD—Metabolism—MTMR3—Crohn's disease	0.000103	0.00232	CbGpPWpGaD
Furosemide—Diarrhoea—Prednisone—Crohn's disease	0.000102	0.00119	CcSEcCtD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000101	0.00227	CbGpPWpGaD
Furosemide—CA5B—Metabolism—MTMR3—Crohn's disease	9.97e-05	0.00224	CbGpPWpGaD
Furosemide—CA7—Metabolism—MTMR3—Crohn's disease	9.97e-05	0.00224	CbGpPWpGaD
Furosemide—Dizziness—Prednisone—Crohn's disease	9.86e-05	0.00115	CcSEcCtD
Furosemide—Vomiting—Prednisone—Crohn's disease	9.48e-05	0.00111	CcSEcCtD
Furosemide—Rash—Prednisone—Crohn's disease	9.4e-05	0.0011	CcSEcCtD
Furosemide—Dermatitis—Prednisone—Crohn's disease	9.39e-05	0.0011	CcSEcCtD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	9.34e-05	0.0021	CbGpPWpGaD
Furosemide—Headache—Prednisone—Crohn's disease	9.34e-05	0.00109	CcSEcCtD
Furosemide—CA12—Metabolism—MTMR3—Crohn's disease	9.24e-05	0.00208	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.13e-05	0.00206	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.13e-05	0.00206	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	8.86e-05	0.00199	CbGpPWpGaD
Furosemide—Nausea—Prednisone—Crohn's disease	8.85e-05	0.00103	CcSEcCtD
Furosemide—Bumetanide—PTGS2—Crohn's disease	8.81e-05	1	CrCbGaD
Furosemide—PGD—Disease—GCKR—Crohn's disease	8.67e-05	0.00195	CbGpPWpGaD
Furosemide—CA4—Metabolism—PLA2G4F—Crohn's disease	8.66e-05	0.00195	CbGpPWpGaD
Furosemide—CA14—Metabolism—FADS1—Crohn's disease	8.54e-05	0.00192	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.44e-05	0.0019	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	8.4e-05	0.00189	CbGpPWpGaD
Furosemide—CA6—Metabolism—FADS1—Crohn's disease	8.32e-05	0.00187	CbGpPWpGaD
Furosemide—CA5A—Metabolism—FADS1—Crohn's disease	8.32e-05	0.00187	CbGpPWpGaD
Furosemide—CA2—Metabolism—PLA2G4F—Crohn's disease	8.3e-05	0.00187	CbGpPWpGaD
Furosemide—PGD—Metabolism—FADS1—Crohn's disease	8.03e-05	0.00181	CbGpPWpGaD
Furosemide—CA14—Metabolism—GPX4—Crohn's disease	7.99e-05	0.0018	CbGpPWpGaD
Furosemide—CA1—Metabolism—PLA2G4F—Crohn's disease	7.96e-05	0.00179	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	7.8e-05	0.00176	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	7.8e-05	0.00176	CbGpPWpGaD
Furosemide—CA6—Metabolism—GPX4—Crohn's disease	7.79e-05	0.00175	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GPX4—Crohn's disease	7.79e-05	0.00175	CbGpPWpGaD
Furosemide—CA7—Metabolism—FADS1—Crohn's disease	7.77e-05	0.00175	CbGpPWpGaD
Furosemide—CA5B—Metabolism—FADS1—Crohn's disease	7.77e-05	0.00175	CbGpPWpGaD
Furosemide—CA14—Metabolism—GCKR—Crohn's disease	7.72e-05	0.00174	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	7.72e-05	0.00174	CbGpPWpGaD
Furosemide—PGD—Disease—SLC11A1—Crohn's disease	7.66e-05	0.00173	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.62e-05	0.00172	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.62e-05	0.00172	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GCKR—Crohn's disease	7.52e-05	0.00169	CbGpPWpGaD
Furosemide—CA6—Metabolism—GCKR—Crohn's disease	7.52e-05	0.00169	CbGpPWpGaD
Furosemide—PGD—Metabolism—GPX4—Crohn's disease	7.52e-05	0.00169	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.46e-05	0.00168	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.38e-05	0.00166	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.38e-05	0.00166	CbGpPWpGaD
Furosemide—CA4—Metabolism—MTMR3—Crohn's disease	7.37e-05	0.00166	CbGpPWpGaD
Furosemide—CA7—Metabolism—GPX4—Crohn's disease	7.27e-05	0.00164	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GPX4—Crohn's disease	7.27e-05	0.00164	CbGpPWpGaD
Furosemide—PGD—Metabolism—GCKR—Crohn's disease	7.26e-05	0.00163	CbGpPWpGaD
Furosemide—CA12—Metabolism—FADS1—Crohn's disease	7.2e-05	0.00162	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.12e-05	0.0016	CbGpPWpGaD
Furosemide—CA2—Metabolism—MTMR3—Crohn's disease	7.06e-05	0.00159	CbGpPWpGaD
Furosemide—CA7—Metabolism—GCKR—Crohn's disease	7.02e-05	0.00158	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GCKR—Crohn's disease	7.02e-05	0.00158	CbGpPWpGaD
Furosemide—CA9—Metabolism—PLA2G4F—Crohn's disease	7e-05	0.00158	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—CRP—Crohn's disease	6.83e-05	0.00154	CbGpPWpGaD
Furosemide—CA1—Metabolism—MTMR3—Crohn's disease	6.77e-05	0.00152	CbGpPWpGaD
Furosemide—CA12—Metabolism—GPX4—Crohn's disease	6.74e-05	0.00152	CbGpPWpGaD
Furosemide—PGD—Disease—RBX1—Crohn's disease	6.57e-05	0.00148	CbGpPWpGaD
Furosemide—PGD—Disease—HSPA1B—Crohn's disease	6.57e-05	0.00148	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	6.56e-05	0.00148	CbGpPWpGaD
Furosemide—CA12—Metabolism—GCKR—Crohn's disease	6.51e-05	0.00147	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.44e-05	0.00145	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.29e-05	0.00142	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—ICAM1—Crohn's disease	6.28e-05	0.00141	CbGpPWpGaD
Furosemide—CA9—Metabolism—MTMR3—Crohn's disease	5.95e-05	0.00134	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	5.87e-05	0.00132	CbGpPWpGaD
Furosemide—PGD—Disease—UBE2D1—Crohn's disease	5.76e-05	0.0013	CbGpPWpGaD
Furosemide—CA4—Metabolism—FADS1—Crohn's disease	5.74e-05	0.00129	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.69e-05	0.00128	CbGpPWpGaD
Furosemide—CA2—Metabolism—FADS1—Crohn's disease	5.5e-05	0.00124	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	5.49e-05	0.00124	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	5.43e-05	0.00122	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—ALB—Crohn's disease	5.39e-05	0.00121	CbGpPWpGaD
Furosemide—CA4—Metabolism—GPX4—Crohn's disease	5.37e-05	0.00121	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.37e-05	0.00121	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.28e-05	0.00119	CbGpPWpGaD
Furosemide—CA1—Metabolism—FADS1—Crohn's disease	5.27e-05	0.00119	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	5.24e-05	0.00118	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.2e-05	0.00117	CbGpPWpGaD
Furosemide—CA4—Metabolism—GCKR—Crohn's disease	5.19e-05	0.00117	CbGpPWpGaD
Furosemide—CA2—Metabolism—GPX4—Crohn's disease	5.15e-05	0.00116	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	4.99e-05	0.00112	CbGpPWpGaD
Furosemide—CA2—Metabolism—GCKR—Crohn's disease	4.98e-05	0.00112	CbGpPWpGaD
Furosemide—CA1—Metabolism—GPX4—Crohn's disease	4.94e-05	0.00111	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	4.9e-05	0.0011	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.86e-05	0.00109	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IFNG—Crohn's disease	4.78e-05	0.00108	CbGpPWpGaD
Furosemide—CA1—Metabolism—GCKR—Crohn's disease	4.77e-05	0.00107	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.75e-05	0.00107	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—CXCL8—Crohn's disease	4.7e-05	0.00106	CbGpPWpGaD
Furosemide—CA9—Metabolism—FADS1—Crohn's disease	4.64e-05	0.00104	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.6e-05	0.00104	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.5e-05	0.00101	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.46e-05	0.001	CbGpPWpGaD
Furosemide—CA9—Metabolism—GPX4—Crohn's disease	4.34e-05	0.000977	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL1B—Crohn's disease	4.26e-05	0.00096	CbGpPWpGaD
Furosemide—CA9—Metabolism—GCKR—Crohn's disease	4.19e-05	0.000944	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.17e-05	0.000938	CbGpPWpGaD
Furosemide—PGD—Disease—SMAD3—Crohn's disease	4.12e-05	0.000928	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.03e-05	0.000907	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.96e-05	0.000892	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.96e-05	0.000892	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	3.93e-05	0.000885	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	3.8e-05	0.000856	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	3.8e-05	0.000856	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	3.8e-05	0.000855	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—STAT3—Crohn's disease	3.78e-05	0.000851	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	3.64e-05	0.000819	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	3.39e-05	0.000762	CbGpPWpGaD
Furosemide—ALB—Hemostasis—F5—Crohn's disease	3.38e-05	0.000761	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.36e-05	0.000757	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.25e-05	0.000731	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TNF—Crohn's disease	3.09e-05	0.000696	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	3.07e-05	0.000691	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.04e-05	0.000684	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.79e-05	0.000629	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	2.75e-05	0.00062	CbGpPWpGaD
Furosemide—PGD—Disease—TYK2—Crohn's disease	2.69e-05	0.000605	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	2.69e-05	0.000605	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IL6—Crohn's disease	2.64e-05	0.000594	CbGpPWpGaD
Furosemide—PGD—Disease—JAK2—Crohn's disease	2.56e-05	0.000577	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL6—Crohn's disease	2.5e-05	0.000562	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.47e-05	0.000556	CbGpPWpGaD
Furosemide—CA14—Metabolism—ALB—Crohn's disease	2.46e-05	0.000553	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	2.46e-05	0.000553	CbGpPWpGaD
Furosemide—PGD—Disease—CD4—Crohn's disease	2.43e-05	0.000547	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—Crohn's disease	2.41e-05	0.000543	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ALB—Crohn's disease	2.39e-05	0.000539	CbGpPWpGaD
Furosemide—CA6—Metabolism—ALB—Crohn's disease	2.39e-05	0.000539	CbGpPWpGaD
Furosemide—PGD—Metabolism—ALB—Crohn's disease	2.31e-05	0.00052	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	2.26e-05	0.00051	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—Crohn's disease	2.24e-05	0.000503	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—Crohn's disease	2.24e-05	0.000503	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLA2G4F—Crohn's disease	2.18e-05	0.000491	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—Crohn's disease	2.15e-05	0.000484	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—Crohn's disease	2.09e-05	0.000472	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—Crohn's disease	2.09e-05	0.000472	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ITGA4—Crohn's disease	2.08e-05	0.000468	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—Crohn's disease	2.07e-05	0.000466	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	2.05e-05	0.000461	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IL3—Crohn's disease	2.03e-05	0.000456	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—Crohn's disease	2.02e-05	0.000455	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	1.98e-05	0.000446	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RASGRP1—Crohn's disease	1.96e-05	0.000441	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—Crohn's disease	1.96e-05	0.00044	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—Crohn's disease	1.96e-05	0.00044	CbGpPWpGaD
Furosemide—PGD—Disease—STAT3—Crohn's disease	1.88e-05	0.000424	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTMR3—Crohn's disease	1.86e-05	0.000418	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	1.85e-05	0.000417	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—Crohn's disease	1.81e-05	0.000408	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.71e-05	0.000385	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.66e-05	0.000373	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—Crohn's disease	1.65e-05	0.000372	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—Crohn's disease	1.58e-05	0.000356	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—Crohn's disease	1.52e-05	0.000342	CbGpPWpGaD
Furosemide—ALB—Metabolism—FADS1—Crohn's disease	1.45e-05	0.000326	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—Crohn's disease	1.44e-05	0.000325	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IL2RA—Crohn's disease	1.42e-05	0.00032	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—Crohn's disease	1.39e-05	0.000312	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX4—Crohn's disease	1.35e-05	0.000305	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—Crohn's disease	1.33e-05	0.0003	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—Crohn's disease	1.33e-05	0.000299	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—Crohn's disease	1.31e-05	0.000296	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCKR—Crohn's disease	1.31e-05	0.000294	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—Crohn's disease	1.17e-05	0.000263	CbGpPWpGaD
Furosemide—ALB—Hemostasis—JAK2—Crohn's disease	9.54e-06	0.000215	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.18e-06	0.000184	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—Crohn's disease	3.64e-06	8.2e-05	CbGpPWpGaD
